Slingshot Insights | Catalyst

Catalyst

Slingshot members are tracking this event:

AbbVie (ABBV) Presents Data From Two Phase 3 Trails Evaluating Elagolix in Premenopausal Women with Endometriosis

Source Link:: https://news.abbvie.com/news/abbvie-announces-positive-pivotal-phase-3-data-demonstrating-investigational-medicine-elagolix-reduces-menstrual-and-non-menstrual-pelvic-pain-associated-with-endometriosis-at-american-society-for-reproductive-medicine-scientific-congress.htm

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Slingshot Insights Explained

JOIN FOR FREE TODAY

Catalyst Date

Occurred on:

Oct 19, 2016

Related Projects

Don’t see a project related to the catalyst you care about?

Related Keywords Phase 3, Data Release, Elagolix, Menstrual And Non-menstrual Pelvic Pain, Endometriosis, Premenopausal Women